- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Amyotrophic Lateral Sclerosis (ALS) in Colombia
Total 259 results
-
International Food Policy Research InstituteCompletedAnemia | Stunting | Undernutrition | Underweight | Maternal MalnutritionUnited States
-
Genentech, Inc.Active, not recruitingMultiple Sclerosis, RelapsingUnited States, Puerto Rico, Kenya
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisFrance, Italy, Spain, Czechia, Hungary, Austria, Belgium, Canada, Portugal, Slovakia, Slovenia
-
EMD SeronoMerck KGaA, Darmstadt, Germany; Ono Pharmaceutical Co. LtdTerminatedMultiple SclerosisUnited States, Belgium, Canada, Czech Republic, Germany, Japan, Poland, Russian Federation, Spain, Ukraine, Greece
-
Hoffmann-La RochePPDRecruitingRelapsing-Remitting Multiple SclerosisUnited States, Belgium, Canada, Spain, India, Italy, Mexico, Portugal, Argentina, Austria, Brazil, United Kingdom, Germany, Netherlands, Serbia, Australia, Bulgaria, France, Greece, Hungary, Poland, Ukraine, Estonia, Denmark, Croatia, Latvia and more
-
Hoffmann-La RocheActive, not recruitingMultiple Sclerosis, Primary ProgressiveUnited States, Canada, Australia, United Kingdom, Hungary, Bulgaria, Puerto Rico, Poland, Argentina, Brazil, Germany, Greece, Italy, Peru, Portugal, Russian Federation, Spain, Turkey, Ukraine, Israel, France, Switzerland, Colombia, Me... and more
-
Novartis PharmaceuticalsActive, not recruitingRelapse Remitting Multiple SclerosisUnited States, Puerto Rico
-
Travanti Pharma Inc.ResearchPointCompletedLateral Epicondylitis | (Tennis Elbow)United States
-
AbbVieCompletedMultiple Sclerosis (MS)United States, Canada
-
BiogenAbbVieTerminatedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States, Denmark, Italy, United Kingdom, Czechia, Canada, Hungary, Spain, Australia, Israel, Georgia, Serbia, Russian Federation, Ukraine, India, Poland, Brazil, France, Argentina, Germany, Greece, Ireland, Mexico, Moldova, Republic... and more
-
University of Colorado, DenverPatient-Centered Outcomes Research Institute; University of Alabama at Birmingham and other collaboratorsCompletedMultiple SclerosisUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States, France, Germany, Spain, Belgium, Czechia, Switzerland, United Kingdom, Austria, New Zealand, Australia, South Africa, Ukraine, Italy, Slovakia, Greece, Poland, Israel, Netherlands, Bulgaria, Serbia, India, Romania, Estonia and more
-
MallinckrodtMallinckrodt ARD Inc.CompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple SclerosisPoland, Hungary, Turkey, Spain, Germany, United States, Canada, Switzerland, Russian Federation, Norway, Italy, Finland
-
BayerCompletedMultiple SclerosisSwitzerland, France, Germany, Indonesia, Korea, Republic of, Spain, Sweden, Thailand, Taiwan, Australia, Austria, Colombia, Czech Republic, Italy, Jordan, Kazakhstan, Lebanon, Mexico, Slovenia, United Kingdom, Bahrain, Egypt, United... and more
-
Ono Pharma USA IncCompletedMultiple SclerosisUnited States, Belgium, Canada, Czech Republic, Germany, Greece, Japan, Poland, Russian Federation, Spain, Ukraine
-
Eicos Sciences, Inc.CompletedRaynaud Phenomenon Secondary to Systemic SclerosisUnited States
-
AbbVieCompletedMultiple Sclerosis (MS)United States, Canada
-
Avanir PharmaceuticalsCompletedMultiple SclerosisUnited States
-
CSL BehringWithdrawnDiffuse Cutaneous Systemic SclerosisBelgium, United States, Italy, Spain, France, Germany, United Kingdom, Argentina, Australia, Canada, Mexico, Poland, Switzerland
-
BiogenCompletedMultiple SclerosisUnited States, Italy, Hungary, United Kingdom, Spain, France, Australia, Germany, Canada, Switzerland, Argentina, Czech Republic, Croatia
-
Merz Pharmaceuticals GmbHCompletedBilateral Blepharospasm (BEB)Greece, Malaysia, Sri Lanka
-
NovartisCompletedMultiple SclerosisUnited States, Turkey, Romania, United Kingdom, Poland, Austria, Canada, Australia
-
Hoffmann-La RocheRecruitingMultiple Sclerosis, Primary ProgressiveCanada, United States, Spain, Croatia, Serbia, Portugal, France, Tunisia, Mexico, Poland, Russian Federation, Australia, Belgium, Italy, United Kingdom, Ukraine, Bulgaria, Colombia, Georgia, Germany, Romania, New Zealand, Lebanon, Aus... and more
-
Corbus Pharmaceuticals Inc.TerminatedDiffuse Cutaneous Systemic SclerosisUnited States, Switzerland, Korea, Republic of, Australia, Netherlands, Israel, United Kingdom, Germany, Japan, Spain, Poland, Canada
-
BiogenElan PharmaceuticalsCompletedMultiple Sclerosis, Relapsing-RemittingUnited Kingdom, United States, Canada, Belgium, Czech Republic, France, Germany, Netherlands
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisSweden, United States, Brazil, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Ukraine, Denmark, Finland, Romania, Canada, France, Hungary, Israel, Switzerland, Serbia, India, Mexico, Poland, Georgia, Ireland, Argentin... and more
-
NovartisCompletedEfficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis (FREEDOMS)Relapsing-remitting Multiple SclerosisCanada, Australia, Israel, Belgium, Czech Republic, Finland, France, Germany, Greece, Lithuania, Netherlands, Poland, Russian Federation, Slovakia, South Africa, Sweden, Switzerland, Turkey, United Kingdom
-
MedDay Pharmaceuticals SATerminatedMultiple SclerosisUnited States, Spain, Canada, Australia, United Kingdom, Belgium, Turkey, Czechia, Poland, Italy, Hungary, Germany, Sweden
-
BiogenAlkermes, Inc.CompletedMultiple SclerosisUnited States, Bulgaria, Poland, Belgium, Canada, Germany, Russian Federation, Serbia, Spain, Ukraine
-
ActelionCompletedMultiple SclerosisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Finland, France, Germany, Hungary, Israel, Italy, Netherlands, Poland, Romania, Russian Federation, Serbia, Spain, Sweden, Switzerland, Ukraine, United Kingdom
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisBelgium, Germany, Italy, Norway, France, Mexico, Australia, Spain, Portugal, Greece, Netherlands, United Kingdom, Czechia, Slovakia, Finland, Canada, Argentina, Brazil
-
Novartis PharmaceuticalsRecruitingRelapsing Multiple SclerosisChina, Spain, Switzerland, Taiwan, United States, Italy, Austria, Belgium, Saudi Arabia, United Arab Emirates, Latvia, Poland, Argentina, India, Croatia, Bulgaria, Malaysia, Slovakia, Israel, Lebanon, Guatemala, Netherlands, Colombia, Chil... and more
-
ActelionCompletedSystemic Sclerosis | UlcersCanada, United States, Belarus, Hungary, Croatia, Australia, Denmark, Ukraine, Bulgaria, Chile, Colombia, Czech Republic, Finland, Germany, India, Italy, Poland, Russian Federation
-
Medstar Health Research InstitutePatty Brisben Foundation For Women's Sexual Health; Society of Gynecologic...RecruitingFractionated CO2 Laser With and Without Clobetasol for Treatment of Vulvar Lichen Sclerosus (VULVIE)Vulvar Lichen SclerosusUnited States
-
Acceleron Pharma, Inc., a wholly-owned subsidiary...Active, not recruitingSystemic Sclerosis With and Without Interstitial Lung DiseaseUnited States, Canada, Italy, Switzerland
-
Johns Hopkins UniversityPatient-Centered Outcomes Research Institute; National Multiple Sclerosis SocietyRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Mapi Pharma Ltd.CompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Belarus, Bosnia and Herzegovina, Bulgaria, Estonia, Georgia, Israel, Moldova, Republic of, Russian Federation, Ukraine
-
Hoffmann-La RocheCompletedSystemic SclerosisBelgium, United Kingdom, Mexico, Poland, United States, Japan, Argentina, Netherlands, Canada, France, Lithuania, Germany, Spain, Bulgaria, Denmark, Greece, Hungary, Italy, Portugal, Puerto Rico, Romania, Switzerland
-
Genentech, Inc.CompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Canada
-
NovartisCompletedMultiple SclerosisUnited States, Canada
-
BiogenCompletedRelapsing Forms of Multiple SclerosisUnited States
-
Millennium Pharmaceuticals, Inc.TerminatedCritical Illness | Enteral Nutrition | Enteral Feeding IntoleranceUnited States, Canada, Australia, United Kingdom
-
Genentech, Inc.Roche Pharma AGCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Canada, Belgium, Spain, France, Switzerland, Ukraine, Mexico, Germany, Bulgaria, United Kingdom, Romania, Czechia, Italy, Russian Federation, Serbia, Slovakia, Denmark
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czechia, Estonia, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Korea, Republic of, Latvia, Moldova, Republic of, Montenegro, North Macedonia and more
-
Novartis PharmaceuticalsCompletedRelapsing Multiple SclerosisBelgium, Italy, United States, Croatia, Spain, Netherlands, Switzerland, Thailand, Israel, Czechia, Estonia, Poland, France, Bulgaria, Russian Federation, Germany, Turkey, Slovakia, Australia, Denmark, Greece, Argentina, India, Hungary, United Kingdom and more
-
Novartis PharmaceuticalsTerminatedPrimary Progressive Multiple SclerosisUnited States, Belgium, Poland, Germany, Hungary, Turkey, Spain, Australia, Canada, Czechia, Switzerland, United Kingdom, Netherlands, France, Italy, Denmark, Finland, Sweden
-
Bristol-Myers SquibbWithdrawnSclerodermaUnited Kingdom, United States, Poland, Canada
-
SanofiActive, not recruitingRelapsing Multiple SclerosisSpain, United States, Mexico, Japan, Austria, Belarus, Bulgaria, Canada, China, Czechia, Denmark, Estonia, Finland, Germany, Italy, Lithuania, Poland, Romania, Russian Federation, Sweden, Taiwan, Turkey, Ukraine, Hong Kong
-
ANRS, Emerging Infectious DiseasesInstitut National de la Santé Et de la Recherche Médicale, FranceCompletedMaternal-fetal Infection TransmissionFrance